IRIS
BOSCHETTI, MARA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 5.130
Totale 5.130
Salva come PNG Salva come JPEG
Nazione #
IT - Italia 5.130
Totale 5.130
Salva come PNG Salva come JPEG
Città #
Genova 3.852
Rapallo 590
Genoa 514
Vado Ligure 157
Bordighera 17
Totale 5.130
Salva come PNG Salva come JPEG
Nome #
Bone turnover and mineral density in adult thalassemic patients: relationships with growth hormone secretory status and circulating somatomedins 246
Effect of environment on growth: auxological and hormonal parameters in African and Italian children 158
Pituitary image: pituicytoma. 151
Autonomic nervous system and cardiovascular risk assessment during one year of growth hormone (GH) replacement therapy in adults with GH deficiency. 151
Characteristics of a nationwide cohort of patients presenting with Isolated Hypogonadotropic Hypogonadism (IHH) 149
Neuroendocrine-immune interactions: the role of cortistatin/somatostatin system 144
Association of kidney disease measures with risk of renal function worsening in patients with type 1 diabetes 141
Partial visual recovery from radiation-induced optic neuropathy after hyperbaric oxygen therapy in a patient with Cushing disease 138
The clinical-molecular interface of somatostatin, dopamine and their receptors in pituitary pathophysiology 136
Preclinical and clinical experiences with the role of dopamine receptors in the treatment of pituitary adenomas 132
Initial staging of lymphoma with octreotide and other receptor imaging agents. 131
Cell specific interaction of pasireotide: review of preclinical studies in somatotroph and corticotroph pituitary cells 131
Pituitary tumor disappearance in a patient with newly diagnosed acromegaly primarily treated with octreotide LAR 128
Grade increases in gastroenteropancreatic neuroendocrine tumor metastases compared to the primary tumor 128
Diabetes secondary to neuroendocrine gastroenteropancreatic tumors 125
Vitamin D increases circulating IGF1 in adults: potential implication for the treatment of GH deficiency 123
Normal age-dependent values of serum insulin growth factor-I: results from a healthy Italian population 122
The IGF system in a case of Costello syndrome 122
Characterization of the IGF system in 15 patients with Alstrom syndrome. 122
Biochemical diagnosis and assessment of disease activity in acromegaly: a two-decade experience. 122
Conventional and nuclear medicine imaging in Ectopic Cushing's syndrome: A systematic review 120
One-year GH replacement therapy reduces early cardiac target organ damage (TOD) in adult GHD patients 118
Twenty years of gastroenteropancreatic neuroendocrine tumors: is reclassification worthwhile and feasible? 116
Interactions between vitamin D and IGF-I: from physiology to clinical practice 115
Role of pituitary dysfunction on cardiovascular risk in primary empty sella patients. 113
P68 Insulin-like growth factor (IGF) binding protein-3 inhibits IGF-II-stimulated IRS-1/PI-3-kinase activity and cell growth in human non-small cell lung cancer (NSCLC) cell lines 113
Dipeptidyl peptidase-4 inhibitors do not alter GH/IGF-I axis in adult diabetic patients 111
P87 Effect of exenatide, sitagliptin and vildagliptin on IGF-I in diabetic patients 110
In memory of Francesco Maria Minuto. 109
Assessment of disease activity in acromegaly by means of a single blood sample: comparison of the 120th minute postglucose value with spontaneous GH secretion and with the IGF system 105
Somatostatin receptor pathophysiology in the neuroendocrine system 101
Role of dopamine receptors in normal and tumoral pituitary corticotropic cells and adrenal cells 100
The undescended testis. Prevalence and clinical features 97
Replacement therapy and cardiovascular diseases 96
Current perspectives on the impact of clinical disease and biochemical control on comorbidities and quality of life in acromegaly 90
Efficacy of a slow-release formulation of lanreotide (Autogel) 120 mg) in patients with acromegaly previously treated with octreotide long acting release (LAR): an open, multicentre longitudinal study. 87
Potential indications for somatostatin analogues: immune system and lymphoproliferative disorders 79
Growth factors and metabolic markers in cord blood: relationship to birth weight and length. 74
"Present and future of immunotherapy in Neuroendocrine Tumors" 64
Emerging drugs for the treatment of acromegaly 54
Nuove potenziali applicazioni degli analoghi della somatostatina 47
The effect of sodium restriction on iodine prophylaxis: a review 42
Octreotide-resistant acromegaly: Challenges and solutions 39
GH Replacement in the Elderly: Is It Worth It? 38
null 37
ESE audit on management of Adult Growth Hormone Deficiency in clinical practice 35
Prevalence of diabetic striatopathy and predictive role of glycated hemoglobin level 31
Impact of microscopic extrathyroidal extension on differentiated thyroid cancer post-surgical risk of recurrence: a retrospective analysis 23
Diabetic striatopathy: an updated overview of current knowledge and future perspectives 22
Possible protective role of metformin therapy on colonic polyps in acromegaly: An exploratory cross-sectional study 22
Modulatory activity of testosterone on growth pattern and IGF-1 levels in vanishing testis syndrome: a case report during 15 years of follow-up 21
Potential indications for somatostatin analogues: immune system and limphoproliferative disorders 17
Case report: Twice-daily tolvaptan dosing regimen in a challenging case of hyponatremia due to SIAD 17
Current perspectives in obesity management: unraveling the impact of different therapy approach in real life obesity care 14
Improved overall survival in patients developing endocrine toxicity during treatment with nivolumab for advanced non-small cell lung cancer in a prospective study 12
Trabecular Bone Score as a Reliable Measure of Lumbar Spine Bone Microarchitecture in Acromegalic Patients 11
Low-grade inflammation, CoVID-19, and obesity: clinical aspect and molecular insights in childhood and adulthood. 11
An unusual cause of adrenal insufficiency with elevation of 17-hydroxyprogesterone: case report 11
The impact of overweight on lipid phenotype in different forms of dyslipidemia: a retrospective cohort study 6
Reply to letter to editor “Knowledge gaps in diabetic striatopathy and other movement disorders in diabetes” 5
Effects of magnesium supplementation on post-thyroidectomy hypocalcemia: a prospective single-center study 1
Totale 5.234
Salva come PNG Salva come JPEG
Categoria #
all - tutte 16.426
article - articoli 15.811
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 615
Totale 32.852
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.197 0 0 68 99 122 137 199 91 122 190 125 44
2020/2021585 25 45 46 126 68 31 30 57 40 56 27 34
2021/2022614 22 21 58 88 10 48 43 128 41 62 25 68
2022/2023692 56 72 15 69 108 99 16 41 102 4 100 10
2023/2024424 15 49 7 60 29 88 29 26 16 28 29 48
2024/2025185 60 81 44 0 0 0 0 0 0 0 0 0
Totale 5.234